Thanks Rob. I know I speak for everyone at Post and everyone else on the call, when I say that we hope your treatment goes well. And we're eager for your full-time return. Before I begin my comments on the performance of the business, I would like to share that out of respect for Rob's privacy, we will not be responding to questions or providing additional information concerning his health and treatment. Now turning to our business. 2023 was a fantastic financial year as we achieved a step-change in adjusted EBITDA, increasing 28% over the prior year. This was driven by exceptional Foodservice results, which reflected volume growth and mix improvement, enhanced by a non-recurring avian influenza pricing benefit. Additionally, we had a very strong start to our entry in the pet food category and recaptured some profit margin in our domestic retail businesses through pricing, significant improvement in labor availability and supply chain performance. We believe this level of consolidated adjusted EBITDA sustainable as we look to fiscal 2024. While the AI pricing benefit has fallen away, we will benefit from a full year of pet food and profit growth in all of our other retail businesses. Before I talk in more detail about each of our segments, I want to spend a few minutes on how we view the state-of-the consumer. The combination of inflation, higher interest rates reduced SNAP benefits, restart of student loan payments and lower savings has caused consumers to pull back on shopping trips. In addition, consumers are being more selective with their spend, often trading down within a category, or shifting into more value categories. At the same time we are seeing consumers prioritize convenience and on the go especially in breakfast. When we think about these consumer trends in the context of our own business, we believe our diversification serves us well as we have meaningful exposure to value products in domestic and international cereal and US pet food, convenience through our side dish business and out-of-home through foodservice. For our premium branded retail products we plan targeted investment behind our category leading brands like Pebbles, Weetabix and Bob Evans to help us retain core consumers, drive trial and incremental volumes. Moving to our segments and starting with Foodservice, we delivered another outsized quarter, fueled by the last of our temporary AI pricing premium. Through volume growth and mix improvement, we now estimate the sustainable quarterly level of adjusted EBITDA for this business to be approximately $95 million before any impact from the ready-to-drink shake manufacturing, which is expected to come online in December. We continue to focus on improving manufacturing and supply chain to support volume growth, serve the business better and lower costs. Shifting to PCB, and starting with our pet food business. Our first five months of ownership have far exceeded our expectations as strong manufacturing performance allowed us to meaningfully increase our order fill rates, reduce out-of-stocks, and replenish our customer inventories. These variables along with lower cost of sales and SG&A drove profit well above our underwriting case. As a reminder, we will see a pullback in this run rate in fiscal 2024 as we make necessary investments in advertising and headcount and begin moving production off the co-manufacturing agreement with Smuckers. We expect to continue to operate meaningfully above our acquisition case, just not at the levels seen in these first five months. The acquisition of Perfection Pet, which we expect will close later in our first fiscal quarter will enhance our flexibility through its capabilities, geography and capacity and greater exposure to private label and co-manufacturing. The US Cereal category remained under pressure with volumes down 6% in the quarter. Our expectation is that the category will return to its pre-pandemic volume trends as we lap the pull-back of SNAP benefits in March. From a share perspective, we were the only branded share gainer this quarter, ending the quarter at 19.6%. Consumers continue trading down to value in private label products and we are well-positioned to capture this move given our strong share in these subcategories. While still below premium branded cereal, our profit margins on value and private label products have meaningfully increased over the past several years. We continue to be pleased with the performance of our Peter Pan brand on a two-year basis which removes the effect of the Jif Recall last year. Peter Pan has grown its dollar market share by 90 basis points. Turning to Weetabix. The macro-environment in the UK continues to be challenged. Similar to US cereal, we are capturing trade down into private label albeit at lower margins. UFIT continues to perform quite nicely and while still small is becoming a more meaningful component of the business. When we acquired the Refrigerated Retail business, it was characterized by strong demand growth with supply-side challenges. During 2023, we improved supply, but experienced the pullback in demand due to elasticities from our inflation-driven pricing. Despite the pullback in demand, we exceeded our adjusted EBITDA expectations for the year with strong manufacturing performance and cost control. Before I turn the call over to Matt, I'd like to make a couple of comments on capital allocation. We continue to actively evaluate M&A opportunities. However, with the challenging capital market backdrop, there is a high bar to clear. Outside of M&A, we remain active in share repurchases and debt repayments, and we have a robust pipeline of value-enhancing capital projects. In closing, I know I speak for Rob in thanking, all of our employees for a very successful 2023. The strength of our operating model, our diverse product offerings and our exceptional management teams give me confidence in our 2024 plans. With that, I'll turn the call over to Matt.